Semaglutide in HFpEF and Obesity, Role of SGLT2 Inhibitors to Highlight ESC 2023

The European Society of Cardiology (ESC) 2023 Congress runs August 25-28 in Amsterdam, the Netherlands.

Related Keywords

University Of Cape Town ,Western Cape ,South Africa ,Netherlands ,Hamburg ,Germany ,Sweden ,Redhill ,North Somerset ,United Kingdom ,Uppsala ,Uppsala Lan ,Amsterdam ,Noord Holland ,Northwestern University ,Illinois ,United States ,Melbourne ,Victoria ,Australia ,Texas ,Sussex ,East Sussex ,Berlin ,Chicago ,Monash ,South Australia ,Dallas ,Scotland ,America ,Eli Lilly ,Bettina Heidecker ,Kosiborod Mcmurray ,Banerjee Sliwa ,Robert Bonow ,Luke Michael ,John Mcmurray ,Stefan James ,Paulus Kirchhof ,Nicholls Kirchhof ,Sadiya Khan ,Stephen Nicholls ,Muthiah Vaduganathan ,Shrilla Banerjee ,Clyde Yancy ,Kausik Ray ,Mikhail Kosiborod ,Javed Butler ,Karen Sliwa ,Boehringer Ingelheim ,Harvard Medical School ,European Society Of Cardiology ,Victorian Heart Institute ,American College Of Cardiology Scientific Sessions ,University Heart Vascular Center ,America Heart Institute ,Saint Luke Health System ,Marlys Haverty Cardiometabolic Center ,Bristol Myers Squibb ,Global Health Equity ,White Research Institute ,Sussex Healthcare ,Monash University ,Charite University Hospital ,University Of Glasgow ,Astrazeneca ,Uppsala University ,European Society ,Saint Luke ,Health System ,Mid America Heart ,Prevalent Heart Failure ,Randomized Trials ,Brigham And Women ,Harvard Medical ,American College ,Cardiology Scientific Sessions ,Total Events Analysis ,University Heart ,Vascular Center ,Inflation Reduction ,New Challenge ,Heart Failure ,Sussex Healthcare Trust ,Cape Town ,Sglt2 ,Obesity ,Hfpef ,Semaglutide ,Mavacamten ,Empagliflozin ,Dapagliflozin ,Atrial Fibrillation ,Noacs ,Health Equity ,